MAPT and Alzheimer disease: These studies suggest that visual abnormalities in AD, historically attributed to brain pathology, may arise directly from pathology in the retina, such as Aβ- and tau-derived neurodegeneration, optic nerve atrophy, inflammation, and vascular attenuation.